The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Biology of CCR5 and Its Role in HIV Infection and Treatment
Abstract
Chemokine receptors are found on cell surfaces and promote cellular migration by chemotaxis. The CC chemokine receptor 5 (CCR5) is used by the human immunodeficiency virus (HIV) to infect cells. Strategies that target human CCR5 are therefore being developed to prevent and treat HIV infection. Antiviral strategies that target a host element necessary for viral replication may be predicted to interfere with the function of that element and may therefore adversely affect the host. We conducted a review of the literature between November 2005 and April 2006 with a focus on articles addressing the genetics and function of CCR5, the effects of CCR5 deletion in human and murine systems, and treatment strategies for HIV infection that target this coreceptor. English-language articles in the human and murine literature published between March 1996 and April 2006 were identified through a search of MEDLINE using CCR5 as the search term. Relevant articles as judged by their titles and abstracts were reviewed in detail. In addition, based on our knowledge of the field and with permission, unpublished work was also reviewed. In this article, we explore the effects that targeting CCR5 may have on host defenses in individuals with immunity already compromised by HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., & Weiss, R. A. (1984) · Nature · doi:10.1038/312763a0 · Cited by 3,533
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,407
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
Mattapallil, J. J., Douek, D. C., Hill, B., Nishimura, Y., Martin, M., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,278
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
The Influence of CCL3L1 Gene-Containing Segmental Duplications on HIV-1/AIDS Susceptibility
Gonzalez, E., Kulkarni, H., Bolivar, H., Mangano, A., Sanchez, R., Catano, G., Nibbs, R. J., Freedman, B. I., Quinones, M. P., Bamshad, M. J., et al. (2005) · Science · doi:10.1126/science.1101160 · Cited by 1,129
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Timing the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Mechanisms That Regulate the Function of the Selectins and Their Ligands
VESTWEBER, D., & BLANKS, J. E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.181 · Cited by 932
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
Yousry, T. A., Major, E. O., Ryschkewitsch, C., Fahle, G., Fischer, S., Hou, J., Curfman, B., Miszkiel, K., Mueller-Lenke, N., Sanchez, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054693 · Cited by 790
Koot, M., Keet, I. P. M., Vos, A. H. V., de Goede, R. E. Y., Roos, M. T. L., Coutinho, R. A., Miedema, F., Schellekens, P. T. A., & Tersmette, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00004 · Cited by 785
Chemokines as regulators of T cell differentiation
Luther, S. A., & Cyster, J. G. (2001) · Nature Immunology · doi:10.1038/84205 · Cited by 736
Immune restoration disease after antiretroviral therapy
French, M. A., Price, P., & Stone, S. F. (2004) · AIDS · doi:10.1097/01.aids.0000131375.21070.06 · Cited by 651
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes
Stephens, J. C., Reich, D. E., Goldstein, D. B., Shin, H. D., Smith, M. W., Carrington, M., Winkler, C., Huttley, G. A., Allikmets, R., Schriml, L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301867 · Cited by 520
CCR5 deficiency increases risk of symptomatic West Nile virus infection
Glass, W. G., McDermott, D. H., Lim, J. K., Lekhong, S., Yu, S. F., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051970 · Cited by 519
REGULATION OF PROTEIN FUNCTION BY GLYCOSAMINOGLYCANS—AS EXEMPLIFIED BY CHEMOKINES
Handel, T. M., Johnson, Z., Crown, S. E., Lau, E. K., Sweeney, M., & Proudfoot, A. E. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161747 · Cited by 508
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
The role of chemokines in linking innate and adaptive immunity
Luster, A. D. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00308-9 · Cited by 474
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., & Burton, D. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.4821-4828.1994 · Cited by 455
Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication
Quiñones-Mateu, M. E., Lederman, M. M., Feng, Z., Chakraborty, B., Weber, J., Rangel, H. R., Marotta, M. L., Mirza, M., Jiang, B., Kiser, P., et al. (2003) · AIDS · doi:10.1097/00002030-200311070-00001 · Cited by 424
Self-citationZimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
Glass, W. G., Lim, J. K., Cholera, R., Pletnev, A. G., Gao, J.-L., & Murphy, P. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042530 · Cited by 391
Chemokine receptor CCR5: insights into structure, function, and regulation
Oppermann, M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.007 · Cited by 376
Prevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5
Lederman, M. M., Veazey, R. S., Offord, R., Mosier, D. E., Dufour, J., Mefford, M., Piatak, M., Lifson, J. D., Salkowitz, J. R., Rodriguez, B., et al. (2004) · Science · doi:10.1126/science.1099288 · Cited by 352
Self-citationT cell costimulation by chemokine receptors
Molon, B., Gri, G., Bettella, M., Gómez-Moutón, C., Lanzavecchia, A., Martínez-A, C., Mañes, S., & Viola, A. (2005) · Nature Immunology · doi:10.1038/ni1191 · Cited by 343
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Ioannidis, J. P. A., Rosenberg, P. S., Goedert, J. J., Ashton, L. J., Benfield, T. L., Buchbinder, S. P., Coutinho, R. A., Eugen-Olsen, J., Gallart, T., Katzenstein, T. L., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00008 · Cited by 300
Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., et al. (2005) · Nature · doi:10.1038/nature04055 · Cited by 298
CC chemokine receptor 5 and renal-transplant survival
Fischereder, M., Luckow, B., Hocher, B., Wüthrich, R. P., Rothenpieler, U., Schneeberger, H., Panzer, U., Stahl, R. A., Hauser, I. A., Budde, K., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04898-4 · Cited by 292
CCR5 Binds Multiple CC-Chemokines: MCP-3 Acts as a Natural Antagonist
Blanpain, C., Migeotte, I., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Vassart, G., Doms, R. W., & Parmentier, M. (1999) · Blood · doi:10.1182/blood.v94.6.1899 · Cited by 287
HIV blocked by chemokine antagonist
Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., & Baggiolini, M. (1996) · Nature · doi:10.1038/383400a0 · Cited by 281
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
Quillent, C., Oberlin, E., Braun, J., Rousset, D., Gonzalez-Canali, G., Métais, P., Montagnier, L., Virelizier, J.-L., Arenzana-Seisdedos, F., & Beretta, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09185-x · Cited by 271
Chemokines: attractive mediators of the immune response
Wong, M. M., & Fish, E. N. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(02)00123-9 · Cited by 266
Aramori, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4606 · Cited by 248
Gröne, H., Weber, C., Weber, K. S. C., Gröne, E. F., Rabelink, T., Klier, C. M., Wells, T. N. C., Proudfoot, A. E., Schlondorff, D., & Nelson, P. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1371 · Cited by 241
Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?
Margolis, L., & Shattock, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1387 · Cited by 235
Epidemiology and Predictive Factors for Chemokine Receptor Use in HIV‐1 Infection
Moyle, G. J., Wildfire, A., Mandalia, S., Mayer, H., Goodrich, J., Whitcomb, J., & Gazzard, B. G. (2005) · The Journal of Infectious Diseases · doi:10.1086/428096 · Cited by 230
Immune reconstitution inflammatory syndrome
BRETON, G. (2009) · Tuberculosis · doi:10.1016/b978-1-4160-3988-4.00067-6 · Cited by 206
Microbicides and other topical strategies to prevent vaginal transmission of HIV
Lederman, M. M., Offord, R. E., & Hartley, O. (2006) · Nature Reviews Immunology · doi:10.1038/nri1848 · Cited by 198
Self-citationLange, C. G., Lederman, M. M., Medvik, K., Asaad, R., Wild, M., Kalayjian, R., & Valdez, H. (2003) · AIDS · doi:10.1097/00002030-200309260-00002 · Cited by 195
Self-citationThe University of North Carolina at Chapel Hill University Libraries (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/81xb-we92 · Cited by 180
Cutting Edge: Human β Defensin 3—A Novel Antagonist of the HIV-1 Coreceptor CXCR4
Feng, Z., Dubyak, G. R., Lederman, M. M., & Weinberg, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.782 · Cited by 170
Self-citationMarozsan, A. J., Kuhmann, S. E., Morgan, T., Herrera, C., Rivera-Troche, E., Xu, S., Baroudy, B. M., Strizki, J., & Moore, J. P. (2005) · Virology · doi:10.1016/j.virol.2005.04.035 · Cited by 160
Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., & Moore, J. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.1876-1885.1998 · Cited by 160
Hartley, O., Gaertner, H., Wilken, J., Thompson, D. A., Fish, R., Ramos, A. G., Pastore, C., Dufour, B., Cerini, F., Melotti, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404802101 · Cited by 160
Self-citationCornò, M. D., Liu, Q., Schols, D., Clercq, E. D., Gessani, S., Freedman, B. D., & Collman, R. G. (2001) · Blood · doi:10.1182/blood.v98.10.2909 · Cited by 154
Use of Chemokine Receptors by Poxviruses
Lalani, A. S., Masters, J., Zeng, W., Barrett, J. W., Pannu, R., Everett, H., Arendt, C., & McFadden, G. (1999) · Science · doi:10.1126/science.286.5446.1968 · Cited by 151
Valdez, H., Smith, K. Y., LANDAY, A. L., Connick, E., Kuritzkes, D. R., Kessler, H. A., Fox, L. M., Spritzler, J., Roe, J. D., Lederman, M. B., et al. (2000) · AIDS · doi:10.1097/00002030-200001070-00002 · Cited by 149
Self-citationHomozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated With Resistance to HIV Infection
Marmor, M. F., Sheppard, H. W., Donnell, D. J., Bozeman, S., Celum, C., Buchbinder, S. P., Koblin, B. A., & Seage, G. R. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200108150-00009 · Cited by 141
CCR5 deficiency decreases susceptibility to experimental cerebral malaria
Belnoue, E., Kayibanda, M., Deschemin, J., Viguier, M., Mack, M., Kuziel, W. A., & Rénia, L. (2003) · Blood · doi:10.1182/blood-2002-05-1493 · Cited by 135
Detection of the CCR5-Δ32 HIV resistance gene in Bronze Age skeletons
Hummel, S., Schmidt, D., Kremeyer, B., Herrmann, B., & Oppermann, M. (2005) · Genes & Immunity · doi:10.1038/sj.gene.6364172 · Cited by 129
Machado, F. S., Koyama, N. S., Carregaro, V., Ferreira, B. R., Milanezi, C. M., Teixeira, M. M., Rossi, M. A., & Silva, J. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/427515 · Cited by 126
Tumour necrosis factor inhibitors
Nash, P. T., & Florin, T. H. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06998.x · Cited by 126
CCR5 Antagonists: Host-Targeted Antivirals for the Treatment of HIV Infection
Westby, M., & van der Ryst, E. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600601 · Cited by 125
Jacobson, J. M., Israel, R. J., Lowy, I., Ostrow, N. A., Vassilatos, L. S., Barish, M., Tran, D. N. H., Sullivan, B. M., Ketas, T. J., O'Neill, T. J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.423-429.2004 · Cited by 123
Algood, H. M. S., & Flynn, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3287 · Cited by 122
Promrat, K., McDermott, D. H., Gonzalez, C. M., Kleiner, D. E., Koziol, D. E., Lessie, M., Merrell, M. N., Soza, A., Heller, T., Ghany, M. G., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50061 · Cited by 120
Glass, W. G., Liu, M. T., Kuziel, W. A., & Lane, T. E. (2001) · Virology · doi:10.1006/viro.2001.1050 · Cited by 117
Müeller, A., & Strange, P. G. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00172-9 · Cited by 113
Goulding, C. (2005) · Gut · doi:10.1136/gut.2004.055699 · Cited by 104
Ruderman, E., & Pope, R. M. (2005) · Arthritis Research · doi:10.1186/ar1688 · Cited by 101
CCR5 mutation and plague protection
Mecsas, J. C., Franklin, G., Kuziel, W. A., Brubaker, R. R., Falkow, S., & Mosier, D. E. (2004) · Nature · doi:10.1038/427606a · Cited by 100
Self-citationRoles of Chemokines and Receptor Polarization in NK-Target Cell Interactions
Nieto, M., Navarro, F., Pérez‐Villar, J. J., del Pozo, M. Á., González‐Amaro, R., Mellado, M., Rodríguez-Frade, J. M., Martínez‐A, C., López‐Botet, M., & Sánchez‐Madrid, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3330 · Cited by 99
Akashi, S., Sho, M., Kashizuka, H., Hamada, K., Ikeda, N., Kuzumoto, Y., Tsurui, Y., Nomi, T., Mizuno, T., Kanehiro, H., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000166338.99933.e1 · Cited by 87
The role of CC chemokine receptor 5 in antiviral immunity
Nansen, A., Christensen, J. P., Andreasen, S. Ø., Bartholdy, C., Christensen, J. E., & Thomsen, A. R. (2002) · Blood · doi:10.1182/blood.v99.4.1237 · Cited by 83
Ambiguous role of CCR5 in Y. pestis infection
Elvin, S. J., Williamson, E. D., Scott, J. C., Smith, J. N., de Lema, G. P., Chilla, S., Clapham, P. R., Pfeffer, K., Schlöndorff, D., & Luckow, B. (2004) · Nature · doi:10.1038/nature02822 · Cited by 74
Unutmaz, D., KewalRamani, V. N., & Littman, D. R. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0134 · Cited by 74
Howard, O. M. Z., Shirakawa, A., Turpin, J. A., Maynard, A. T., Tobin, G. J., Carrington, M. N., Oppenheim, J. J., & Dean, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16228 · Cited by 72
Castagna, A., Biswas, P., Beretta, A., & Lazzarin, A. (2005) · Drugs · doi:10.2165/00003495-200565070-00001 · Cited by 68
Macrophage Inflammatory Protein-1β Induces Migration and Activation of Human Thymocytes
Dairaghi, D. J., Franz-Bacon, K., Callas, E., Cupp, J. E., Schall, T. J., Tamraz, S., Boehme, S. A., Taylor, N. N., & Bacon, K. B. (1998) · Blood · doi:10.1182/blood.v91.8.2905.2905_2905_2913 · Cited by 59
Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids
Tersmette, M., van Dongen, J. J. M., Clapham, P. R., de Goede, R. E. Y., Wolvers-Tettero, I. L. M., Kessel, A. G. V., Huisman, J., Weiss, R. A., & Miedema, F. F. (1989) · Virology · doi:10.1016/0042-6822(89)90266-3 · Cited by 53
Heise, C. C., Vogel, P., Miller, C. J., Lackner, A. A., & Dandekar, S. (1993) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.1993.tb00658.x · Cited by 45
CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?
Ahlenstiel, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh239 · Cited by 35
Jasin, M., Page, K. A., & Littman, D. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.440-444.1991 · Cited by 34
Age-Dependent Role for CCR5 in Antiviral Host Defense against Herpes Simplex Virus Type 2
Ank, N., Petersen, K., Malmgaard, L., Mogensen, S. C., & Paludan, S. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9831-9841.2005 · Cited by 26
Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patients
Deeks, S. G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68280-9 · Cited by 21
Cited by
The emerging role of epigenetic therapeutics in immuno-oncology
Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R., & Baylin, S. B. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0266-5 · Cited by 433
Bosinger, S. E., Li, Q., Gordon, S. N., Klatt, N. R., Duan, L., Xu, L., Francella, N., Sidahmed, A., Smith, A. J., Cramer, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40115 · Cited by 409
Esté, J. A., & Telenti, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61052-6 · Cited by 287
Metadata
- Authors
- Lederman, M. M., Penn-Nicholson, A., Cho, M., & Mosier, D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-08-16
- Volume
- 296
- Issue
- 7
- Pages
- 815
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2004258189
- Cited by
- 266
- References
- 95
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.